Skip to main content

Advertisement

Fig. 5 | Allergy, Asthma & Clinical Immunology

Fig. 5

From: The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option

Fig. 5

(Reprinted with permission from Klimek et al. [126])

Effect of MP-AzeFlu on visual analogue scale (VAS) score over time. Data presented as mean and standard deviation. AR allergic rhinitis, CDSS clinical decision support system, MP-AzeFlu, a novel formulation of an intranasal antihistamine, azelastine hydrochloride, and an intranasal corticosteroid, fluticasone propionate, in a single spray

Back to article page